* P3 Health Partners Inc PIII.OQ reported a quarterly
adjusted
loss of 29 cents per share for the quarter ended September 30,
lower than the same quarter last year, when the company reported
EPS of -12 cents. The mean expectation of five analysts for the
quarter was for a loss of 4 cents per share. Wall Street
expected results to range from -6 cents to -3 cents per share.
* Revenue rose 25.6% to $362.12 million from a year ago;
analysts
expected $364.45 million.
* P3 Health Partners Inc's reported EPS for the quarter was
a loss
of 29 cents.
* The company reported a quarterly loss of $46.51 million.
* P3 Health Partners Inc shares had risen by 1.1% this
quarter and
lost 72.3% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"
Wall Street's median 12-month price target for P3 Health
Partners Inc is 1.00
This summary was machine generated from LSEG data November 13 at
02:25 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 -0.04 -0.29 Missed
Jun. 30 2024 -0.05 -0.09 Missed
Mar. 31 2024 -0.11 -0.16 Missed
Dec. 31 2023 -0.11 -0.22 Missed